Search results
Q3 2025 EPS Estimates for Teva Pharmaceutical Industries Limited Boosted by Analyst (NYSE:TEVA)
ETF DAILY NEWS· 1 day agoTeva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Zacks Research lifted their Q3 2025 EPS estimates for shares of Teva
Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for...
Zacks via Yahoo Finance· 2 days agoEvaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended...
Headlands Technologies LLC Sells 16,858 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)
ETF DAILY NEWS· 2 days agoHeadlands Technologies LLC decreased its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 83.0% in the fourth quarter, according ...
Teva's Revive Collections Travels Back to the 2000s, Photos
Footwear News via Yahoo News· 4 days agoCelebrating its 40th anniversary and giving continuity to its Revive Collections, Teva has launched...
Generic Drug Giant Teva Hires New Legal Chief After DOJ Deal
Bloomberg Law· 5 days agoTeva Pharmaceutical Industries Ltd. has a new chief legal officer in David McAvoy, who succeeds David Stark as the top lawyer for the world’s largest generic drug manufacturer.
21 best sandals for walking all day long, according to podiatrists
CNN via Yahoo News· 5 days agoShe recommends the strappy Kayla Sport sandals for their anatomically contoured footbed and their...
FTC Weighs In on Orange Book Listing of Drug-Device Patents | JD Supra
JD Supra· 3 days agoThe Situation: On March 22, 2024, the Federal Trade Commission ("FTC") filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et al. v. Amneal Pharmaceuticals ...
Spring Has Sprung Obviousness Trends from the Federal Circuit
The National Law Review· 4 days agoAt the beginning of the month, in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc....
Earnings call: Corcept Therapeutics raises 2024 revenue guidance By Investing.com
Investing.com· 3 days agoThe company has also raised its revenue guidance for the full year to between $620 million and $650...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 6 days agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...